Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesis of dronedarone

A synthetic method, the technique of dronedarone, is applied in the field of synthetic process route of the pharmaceutical compound dronedarone, which can solve the problems of low yield, cumbersome yield, and low yield, and achieve high yield, cumbersome operation, The effect of simple operation process

Active Publication Date: 2012-09-12
FUJIAN COSUNTER PHARMA
View PDF1 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Route (1) involves cumbersome operations in literature reports and the yield is very high, and the reproducibility of the reaction is poor; although the steps of route (2) are short, more expensive catalysts are used, and it is not easy to carry out large-scale production; The route (3) has a long step and a low yield; the route (4) has a long step and a large amount of mixed acid is used in the nitration process, which is not conducive to the treatment of the three wastes. In addition, the yield of the whole route is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesis of dronedarone
  • Method for synthesis of dronedarone
  • Method for synthesis of dronedarone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] 1, the preparation of 2-chloromethyl-4-nitrophenol

[0045] Add 60g of p-nitrophenol, 26.16g of paraformaldehyde, 432mL of concentrated hydrochloric acid and 5mL of concentrated HCl into a 1L three-neck flask 2 SO 4 , stirred, heated to 88 ~ 90 ° C, and reacted at this temperature for 4h. The reaction solution was cooled to room temperature, filtered, and the resulting solid was dried under reduced pressure to obtain 75.47 g of off-white to off-white solid, mp 121-125°C.

[0046] 2. Preparation of 2-hydroxy-5-nitrobenzyltriphenylphosphonium chloride

[0047] Add 50g of 2-chloromethyl-4-nitrophenol, 69.80g of triphenylphosphine and 1500mL of chloroform into a 3L three-necked flask, and heat to reflux for 1h. The reaction liquid was cooled to normal temperature, filtered, and dried to obtain 115.63 g of off-white to white solid, yield 96.4%, mp 262-265°C.

[0048] 3. Preparation of 2-n-butyl 5-nitrobenzofuran

[0049]Add 400mL of toluene, 45.4g of triethylamine, 60.1...

Embodiment 2

[0063] 1, the preparation of 2-chloromethyl-4-nitrophenol

[0064] Add 45g of p-nitrophenol, 19.6g of paraformaldehyde, 324mL of concentrated hydrochloric acid and 3mL of phosphoric acid into a 1L three-necked flask, stir, heat to 88-90°C, and react at this temperature for 4h. The reaction solution was cooled to room temperature, filtered, and the resulting solid was dried under reduced pressure to obtain 36.5 g of off-white to off-white solid, mp 124-127°C.

[0065] 2. Preparation of 2-hydroxy-5-nitrobenzyltriphenylphosphonium chloride

[0066] Add 50g of 2-chloromethyl-4-nitrophenol, 69.80g of triphenylphosphine and 1500mL of chloroform into a 3L three-necked flask, and heat to reflux for 1h. The reaction liquid was cooled to normal temperature, filtered, and dried to obtain 115.63 g of off-white to white solid, yield 96.4%, mp 262-265°C.

[0067] 3. Preparation of 2-n-butyl 5-nitrobenzofuran

[0068] Add 400mL of toluene, 45.4g of triethylamine, 60.11g of 2-hydroxy-5-nit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for synthesis of dronedarone. The method comprises the following steps that 1), p-nitrophenol, paraformaldehyde and concentrated hydrochloric acid as raw materials undergo a condensation reaction in the presence of concentrated hydrochloric acid or phosphoric acid as a catalyst to produce 2-chloromethyl-4-nitrophenol; 2), 2-chloromethyl-4-nitrophenol and triphenylphosphine undergo a reflux reaction in the presence of chloroform to produce 2-hydroxy-5-nitrobenzyl-triphenyl-phosphonium chloride, and 3), 2-hydroxy-5-nitrobenzyl-triphenyl-phosphonium chloride and n-valeryl chloride undergo a condensation reaction in a toluene solution in the presence of triethylamine and n-pentanoic acid as catalysts to produce 2-(n-butyl)-5-nitrobenzofuran.

Description

technical field [0001] The present invention relates to a synthesis process route of the pharmaceutical compound dronedarone, in particular to the process conditions and methods for preparing corresponding intermediates in the process route. Background technique [0002] The chemical structure of dronedarone (common name: Dronedarone) is similar to the standard drug amiodarone for the treatment of atrial fibrillation, and the mechanism of action is the same, both of which are potassium ion channel blockers. European patent EP471609 reports that dronedarone has special significance as an antiarrhythmic drug, which can significantly reduce the morbidity and mortality of paroxysmal or persistent atrial fibrillation or atrial flutter; and can effectively prevent certain types of myocardial infarction Clinically, its hydrochloride, namely dronedarone hydrochloride, is usually used clinically. [0003] In the process of preparing dronedarone, 2-n-butyl 5-nitrobenzofuran is a key ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D307/80
Inventor 李国栋张明亮杨敏曾杰文陈仕魁杨喜鸿
Owner FUJIAN COSUNTER PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products